Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ).
NIH Spending Category: Antimicrobial Resistance; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Orphan Drug; Rare Diseases; Tuberculosis
Project Terms: aerosolized; drug efficacy; Drug Formulations; Drug Kinetics; Multidrug-Resistant Tuberculosis; Pharmaceutical Preparations; System; Testing; Toxic effect